只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-01 2026-07-07 | TMC TMC the metals Co Inc. | Heerema Edward TenPercentOwner | 买入（P） | 7,305,567 | — | — | 62,419,168 | SEC |
| 2026-07-01 2026-07-07 | TMC TMC the metals Co Inc. | Argentum Cedit Virtuti NV TenPercentOwner | 买入（P） | 7,305,567 | — | — | 62,419,168 | SEC |
| 2026-07-01 2026-07-07 | TMC TMC the metals Co Inc. | Stichting Administratiekantoor Aequa Lance Foundation TenPercentOwner | 买入（P） | 7,305,567 | — | — | 62,419,168 | SEC |
| 2026-06-11 2026-06-12 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 9,891 | US$4.04 | US$39,959.64 | 7,348,439 | SEC |
| 2026-06-11 2026-06-11 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 22,887 | US$4.04 | US$92,463.48 | 7,376,150 | SEC |
| 2026-06-10 2026-06-12 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 14,715 | US$4.02 | US$59,154.30 | 7,338,548 | SEC |
| 2026-06-10 2026-06-11 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 29,430 | US$4.02 | US$118,308.60 | 7,353,263 | SEC |
| 2026-06-02 2026-06-02 | TMC TMC the metals Co Inc. | May Brendan Director | 卖出（S） | 20,768 | US$6.42 | US$133,330.56 | 193,346 | SEC |
| 2026-06-01 2026-06-01 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 50,000 | US$3.56 | US$178,000.00 | 7,323,833 | SEC |
| 2026-05-28 2026-05-28 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 61,202 | US$3.02 | US$184,830.04 | 7,273,833 | SEC |
| 2026-05-27 2026-05-28 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 49,810 | US$2.87 | US$142,954.70 | 7,212,631 | SEC |
| 2026-05-26 2026-05-28 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 4,508 | US$2.79 | US$12,577.32 | 7,162,821 | SEC |
| 2026-05-14 2026-05-14 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 61,750 | US$2.62 | US$161,785.00 | 7,158,313 | SEC |
| 2026-05-13 2026-05-14 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 49,013 | US$2.46 | US$120,571.98 | 7,096,563 | SEC |
| 2026-05-12 2026-05-14 | TMCI TREACE MEDICAL CONCEPTS, INC. | Treace John T. Director,Officer,TenPercentOwner · Chief Executive Officer | 买入（P） | 43,000 | US$2.17 | US$93,310.00 | 7,047,550 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| TMCR | 33,220.4601 | 20,934 | 41,943.9433 | 79.20% | Q, N |
| TMCWW | 74,595 | 6,550 | 136,214 | 54.76% | Q |
| TMC | 717,655.066 | 0 | 1,533,445.6312 | 46.80% | B, Q, N |
| TMCI | 30,065.3875 | 0 | 65,177.9111 | 46.13% | Q, N |
| PTMC | 4,355.5141 | 660 | 9,737.9884 | 44.73% | Q |